Constantine Chinoporos
Director de Operaciones en APPLIED THERAPEUTICS, INC. .
Fortuna: 1 M $ al 31/05/2024
Perfil
Constantine Chinoporos is currently the Chief Operating & Business Officer at Applied Therapeutics, Inc. Prior to his current position, he served as the Chief Business Officer at Boston Pharmaceuticals, Inc. from 2015 to 2021 and at Albireo Pharma, Inc. from 2021 to 2023.
He also held a position as the Head of Corporate Development at Genzyme Corp.
Mr. Chinoporos completed his undergraduate degree at Cornell University and earned an MBA from Johnson Graduate School of Management.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/12/2023 | 300 000 ( 0.26% ) | 1 M $ | 31/05/2024 |
Cargos activos de Constantine Chinoporos
| Empresas | Cargo | Inicio |
|---|---|---|
| APPLIED THERAPEUTICS, INC. | Director de Operaciones | 28/12/2023 |
Antiguos cargos conocidos de Constantine Chinoporos.
| Empresas | Cargo | Fin |
|---|---|---|
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 01/03/2023 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/10/2021 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formación de Constantine Chinoporos.
| Cornell University | Undergraduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| APPLIED THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Constantine Chinoporos
